Lyndra Therapeutics



Lyndra Therapeutics is a novel technology platform reinventing medicine for a healthier world.

  • 101 - 250


Last Funding Type
Series B
Last Funding Money Raised
Biotechnology,Clinical Trials,Health Care,Pharmaceutical
Founded date
Jan 14, 2015
Number Of Employee
101 - 250
Operating Status

Lyndra Therapeutics is reinventing medicines to make daily pills a thing of the past, replacing them with its oral, ultra-long-acting, sustained-release therapies. Administering and conveniently distributing medicines in weekly or longer-term doses – including using polypill approaches – will improve safety, efficacy, and adherence to maximize global health impact and lower overall healthcare costs.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
Lyndra Therapeutics has raised a total of $144.40M in funding over 2 rounds. Their latest funding was raised on Jun 24, 2021 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 24, 2021 Series C $60.50M 1 Detail
Feb 11, 2019 Series B $60.90M 3 Detail
Apr 13, 2017 Series A $23M 1 Detail


Number of Lead Investors
Number of Investors
Lyndra Therapeutics is funded by 3 investors. HOPU Investment Management Company and Orient Life are the most recent investors.
Investor Name Lead Investor Funding Round
HOPU Investment Management Company Series C
Orient Life Series B
Healthlink Capital Series B